DE11786796T8 - Antigenpeptid und verwendung davon - Google Patents

Antigenpeptid und verwendung davon Download PDF

Info

Publication number
DE11786796T8
DE11786796T8 DE11786796T DE11786796T DE11786796T8 DE 11786796 T8 DE11786796 T8 DE 11786796T8 DE 11786796 T DE11786796 T DE 11786796T DE 11786796 T DE11786796 T DE 11786796T DE 11786796 T8 DE11786796 T8 DE 11786796T8
Authority
DE
Germany
Prior art keywords
antigenpeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE11786796T
Other languages
English (en)
Other versions
DE11786796T1 (de
Inventor
Hasumi Kenichiro
Kuraya Mikio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE11786796T1 publication Critical patent/DE11786796T1/de
Application granted granted Critical
Publication of DE11786796T8 publication Critical patent/DE11786796T8/de
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0208Specific bacteria not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/64Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645Dendrimers; Multiple antigen peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE11786796T 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon Active DE11786796T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39657410P 2010-05-27 2010-05-27
US396574P 2010-05-27
EP11786796.0A EP2430157B1 (de) 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon

Publications (2)

Publication Number Publication Date
DE11786796T1 DE11786796T1 (de) 2013-03-21
DE11786796T8 true DE11786796T8 (de) 2013-04-25

Family

ID=45004081

Family Applications (1)

Application Number Title Priority Date Filing Date
DE11786796T Active DE11786796T8 (de) 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon

Country Status (10)

Country Link
US (4) US8784830B2 (de)
EP (2) EP2430157B1 (de)
JP (2) JP5243624B2 (de)
CN (2) CN102471770B (de)
AU (1) AU2011259204B2 (de)
DE (1) DE11786796T8 (de)
HK (1) HK1168622A1 (de)
MY (1) MY167069A (de)
SG (1) SG194420A1 (de)
WO (2) WO2011149099A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE11786796T8 (de) * 2010-05-27 2013-04-25 Hasumi Kenichiro Antigenpeptid und verwendung davon
JP2012058530A (ja) * 2010-09-09 2012-03-22 Seiko Epson Corp シャッター眼鏡、及び、画像表示システム
WO2013142378A1 (en) * 2012-03-17 2013-09-26 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
JP2019514885A (ja) 2016-04-21 2019-06-06 ネイキッド バイオーム,インク. 皮膚障害の処置のための組成物および方法
KR101873827B1 (ko) 2016-10-25 2018-07-03 주식회사 라파스 여드름 개선용 마이크로니들 패취 및 그 제조방법
BR112022016555A2 (pt) 2020-02-21 2022-11-16 Origimm Biotechnology Gmbh Tratamento profilático e imunoterapêutico para propionibacterium acnes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741262B1 (fr) * 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
JP2004520803A (ja) 2000-04-21 2004-07-15 コリクサ コーポレイション 尋常性挫瘡の治療および診断のための組成物および方法
US7939567B2 (en) * 2006-02-24 2011-05-10 Blue Blood Biotech Corp. Dextromethorphan-based method for treating acne
WO2010039750A2 (en) * 2008-10-01 2010-04-08 Monsanto Technology Llc Transgenic plants with enhanced agronomic traits
CA2776949A1 (en) * 2008-12-05 2010-06-10 The Regents Of The University Of California Methods and compositions for treating p.acnes
UA107490C2 (uk) * 2010-04-07 2015-01-12 Еббві Інк. TNF-α-ЗВ'ЯЗУВАЛЬНИЙ БІЛОК
DE11786796T8 (de) 2010-05-27 2013-04-25 Hasumi Kenichiro Antigenpeptid und verwendung davon

Also Published As

Publication number Publication date
US20120301495A1 (en) 2012-11-29
SG194420A1 (en) 2013-12-30
JP5243624B2 (ja) 2013-07-24
US9895432B2 (en) 2018-02-20
US20150023997A1 (en) 2015-01-22
MY167069A (en) 2018-08-09
DE11786796T1 (de) 2013-03-21
EP3157554A1 (de) 2017-04-26
EP2430157A1 (de) 2012-03-21
US20180133299A1 (en) 2018-05-17
US10426825B2 (en) 2019-10-01
EP2430157B1 (de) 2013-05-08
JP2012528566A (ja) 2012-11-15
US20200009239A1 (en) 2020-01-09
CN102471770A (zh) 2012-05-23
WO2011149099A1 (en) 2011-12-01
US8784830B2 (en) 2014-07-22
JP2017520556A (ja) 2017-07-27
HK1168622A1 (en) 2013-01-04
EP3157554A4 (de) 2018-02-14
CN106687131A (zh) 2017-05-17
EP2430157A4 (de) 2012-07-04
AU2011259204B2 (en) 2015-05-21
WO2015200254A1 (en) 2015-12-30
US11020468B2 (en) 2021-06-01
CN102471770B (zh) 2013-07-24

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HK1252803A1 (zh) 5-位修飾的嘧啶及它們的用途
BR112012017441A2 (pt) compostos e métodos
DK2552261T3 (da) Propfilter med proprum med aromakugle
DK2594567T3 (da) Heterocykliske alkynylbenzenforbindelser og anvendelser deraf
BR112012031855A2 (pt) composição e artigo
BR112012027165A2 (pt) composição e artigo
BR112012027159A2 (pt) estrutura e método
DK2613884T3 (da) Findelingsindretning
BR112012028633A2 (pt) composição reticulada e artigo
FR2956961B1 (fr) Oreiller orthopedique
DK2642992T3 (da) Forbindelser og anvendelse deraf
DE11786796T8 (de) Antigenpeptid und verwendung davon
FR2964937B1 (fr) Triporteur et direction de triporteur
IT1401910B1 (it) Composizione fotoattiva stabilizzata e suo utilizzo
BR112012021749A2 (pt) processos e compostos
FR2965717B1 (fr) Fauteuil roulant
DK2723873T4 (da) P0-gen-nedreguleringskonstruktioner og anvendelse deraf
ES1071902Y (es) Mecanismo de termosoldadura y precorte
FR2965715B1 (fr) Fauteuil roulant
FI20105760A0 (fi) Menetelmä ja järjestely
BR112013014731A2 (pt) tamavidina modificada
BR112013013441A2 (pt) composição de adesivo-engomadura e métodos relacionados
DK2576910T3 (da) Fremgangsmåde og element
DK2532744T3 (da) Glycerin-3-phosphatacyltransferasehomolog og anvendelse deraf